scholarly journals Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study

2017 ◽  
Vol 48 (3) ◽  
pp. E146-E154 ◽  
Author(s):  
Goki Suda ◽  
Jun Ito ◽  
Atsushi Nagasaka ◽  
Yoshiya Yamamoto ◽  
Ken Furuya ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Combination Therapy ◽  
Pegylated Interferon ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Hepatitis C Virus Infection ◽  
Genotype 1 ◽  
Randomized Controlled

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection

2015 ◽  
Vol 163 (11) ◽  
pp. 809 ◽  
Author(s):  
Stephen Pianko ◽  
Steven L. Flamm ◽  
Mitchell L. Shiffman ◽  
Sonal Kumar ◽  
Simone I. Strasser ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Combination Therapy ◽  
Hepatitis C Virus Infection ◽  
Genotype 1

scholarly journals Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

Hepatology ◽  
2010 ◽  
Vol 52 (3) ◽  
pp. 822-832 ◽  
Author(s):  
Andrew J. Muir ◽  
Mitchell L. Shiffman ◽  
Atif Zaman ◽  
Boris Yoffe ◽  
Andrew de la Torre ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Pegylated Interferon ◽  
Hepatitis C Virus Infection ◽  
Genotype 1 ◽  
Interferon Lambda ◽  
Phase 1B
Sign in / Sign up

Export Citation Format

Share Document